Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (3): 89-95.doi: 10.6040/j.issn.1671-7554.0.2021.1046

Previous Articles    

Value of preoperative multiphase MRI for predicting microvascular invasion and early recurrence of 169 hepatocellular carcinoma

ZUO Liping1,2, JIANG Fengyang1,2, ZHOU Binbin1,2, FAN Jinlei1,2, LIANG Yongfeng2, DENG Zhanhao1,2, YU Dexin1,2   

  1. 1. Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China;
    2. Department of Radiology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2022-03-09

Abstract: Objective To investigate the significance of preoperative contrast-enhanced multiphase magnetic resonance imaging(MRI)in the identification of microvascular invasion and early recurrence in patients with hepatocellular carcinoma(HCC). Methods This retrospective study included 169 HCC patients treated with surgical resection during Feb. 2015 and Jan. 2019 who underwent preoperative multiphase MRI. Clinical, biologic and imaging features associated with microvascular invasion and early recurrence(within 2 years)were analyzed. MRI predictors for microvascular invasion were evaluated with univariate and multivariate Logistics analysis. Predictors of early recurrence were determined with Logistic regression and multivariate Cox analysis. Early recurrence and overall recurrence in microvascular invasion were evaluated with Kaplan-Meier analysis. Results In multivariate Logistics analysis, tumor size >5 cm(OR=7.1, 95%CI: 1.3-38.8,P=0.023), corona enhancement(OR=2.1, 95%CI: 0.8-5.5, P=0.018), and non-smooth tumor margin(OR=3.3, 95%CI: 1.0~10.5, P=0.045)were independent significant variables associated with microvascular invasion. In multivariate Cox analysis, microvascular invasion was a non-statistically significant factor(P=0.09). Kaplan-Meier curve showed that patients with microvascular invasion had lower early and overall recurrence-free survival. Conclusion Tumor size >5 cm, corona enhancement, and non-smooth tumor margin are independent predictors for microvascular invasion in HCC. Microvascular invasion is an important prognostic indicator but with a poor ability to predict early recurrence.

Key words: Hepatocellular carcinoma, Magnetic resonance imaging, Microvascular invasion, Early recurrence, Diagnosis

CLC Number: 

  • R574
[1] Fitzmaurice C, Allen C, Barber RM, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study [J]. JAMA Oncol, 2017, 3(4): 524-548.
[2] Tabrizian P, Jibara G, Shrager B, et al. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis [J]. Ann Surg, 2015, 261(5): 947-955.
[3] 胡艳, 陆笑非, 周铁军, 等. 3.0TMR扩散加权成像预测肝细胞肝癌分化程度和微血管侵犯的价值[J]. 实用放射学杂志, 2019, 35(12): 1948-1952. HU Yan, LU Xiaofei, ZHOU Tiejun, et al. Differentiation grade and microvascular invasion for hepatocellular carcinoma: assessed by diffusion weighted imaging at 3.0T MR [J]. Journal of Practical Radiology, 2019, 35(12): 1948-1952.
[4] Lauwers GY, Terris B, Balis UJ, et al. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index [J]. Am J Surg Pathol, 2002, 26(1): 25-34.
[5] Hong SB, Choi SH, Kim SY, et al. MRI features for predicting microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis [J]. Liver Cancer, 2021, 10(2): 94-106.
[6] Yamashita Y, Tsuijita E, Takeishi K, et al. Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm [J]. Ann Surg Oncol, 2012, 19(6): 2027-2034.
[7] Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy [J]. J Hepatol, 2003, 38(2): 200-207.
[8] 孔伟, 林文聪, 陈文坚, 等. LI-RADS CT诊断法则对诊断肝癌的临床价值[J]. 实用放射学杂志, 2021, 37(3): 407-411. KONG Wei, LIN Wencong, CHEN Wenjian, et al. The clinical value of CT LI-RADS diagnostic algorithm in the diagnosis of hepatocellular carcinoma [J]. Journal of Practical Radiology, 2021, 37(3): 407-411.
[9] Huang M, Liao B, Xu P, et al. Prediction of microvascular invasion in hepatocellular carcinoma: preoperative Gd-EOB-DTPA-Dynamic enhanced MRI and histopathological correlation [J]. Contrast Media Mol Imaging, 2018, 2018: 9674565. doi:10.1155/2018/9674565.
[10] Ryu T, Takami Y, Wada Y, et al. A clinical scoring system for predicting microvascular invasion in patients with hepatocellular carcinoma within the Milan criteria [J]. J Gastrointest Surg, 2019, 23(4): 779-787.
[11] Kim AY, Sinn DH, Jeong WK, et al. Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma [J]. J Hepatol, 2018, 68(6): 1144-1152.
[12] Ariizumi S, Kitagawa K, Kotera Y, et al. A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium(Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma [J]. J Hepatobiliary Pancreat Sci, 2011, 18(4): 575-585.
[13] Lee S, Kim SH, Lee JE, et al. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma [J]. J Hepatol, 2017, 67(3): 526-534.
[14] Rhee H, An C, Kim HY, et al. Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features [J]. Liver Cancer, 2019, 8(1): 24-40.
[15] Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation [J]. Ann Surg, 2021, 273(3): 564-571.
[16] Kim H, Park MS, Choi JY, et al. Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? [J]. Eur Radiol, 2009, 19(7): 1744-1751.
[17] Witjes CD, Willemssen FE, Verheij J, et al. Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI [J]. J Magn Reson Imaging, 2012, 36(3): 641-647.
[18] Suh YJ, Kim MJ, Choi JY, et al. Preoperative prediction of the microvascular invasion of hepatocellular carcinoma with diffusion-weighted imaging [J]. Liver Transpl, 2012, 18(10): 1171-1178.
[19] Xu P, Zeng M, Liu K, et al. Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging? [J]. J Gastroenterol Hepatol, 2014, 29(2): 330-336.
[20] Zhao J, Li X, Zhang K, et al. Prediction of microvascular invasion of hepatocellular carcinoma with preoperative diffusion-weighted imaging: a comparison of mean and minimum apparent diffusion coefficient values [J]. Medicine(Baltimore), 2017, 96(33): e7754.
[21] Zhao W, Liu W, Liu H, et al. Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging [J]. PLoS One, 2018, 13(5): e0197488.
[22] Rodríguez-Perálvarez M, Luong TV, Andreana L, et al. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability [J]. Ann Surg Oncol, 2013, 20(1): 325-339.
[23] Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma [J]. Liver Transpl, 2005, 11(9): 1086-1092.
[24] Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features [J]. Radiology, 2014, 273(1): 30-50.
[25] Matsui O, Kobayashi S, Sanada J, et al. Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation(angiography-assisted CT)with special reference to multi-step hepatocarcinogenesis [J]. Abdom Imaging, 2011, 36(3): 264-272.
[26] Li M, Xin Y, Fu S, et al. Corona enhancement and mosaic architecture for prognosis and selection between of liver resection versus transcatheter arterial chemoembolization in single hepatocellular carcinomas >5 cm without extrahepatic metastases: an imaging-based retrospective study [J]. Medicine(Baltimore), 2016, 95(2): e2458.
[27] Song L, Li J, Luo Y. The importance of a nonsmooth tumor margin and incomplete tumor capsule in predicting HCC microvascular invasion on preoperative imaging examination: a systematic review and meta-analysis [J]. Clin Imaging, 2021, 76: 77-82. doi: 10.1016/j.clinimag.2020.11.057.
[28] Sasaki M, Yamada K, Watanabe Y, et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study [J]. Radiology, 2008, 249(2): 624-630.
[29] Kierans AS, Leonardou P, Hayashi P, et al. MRI findings of rapidly progressive hepatocellular carcinoma [J]. Magn Reson Imaging, 2010, 28(6): 790-796.
[30] An C, Rhee H, Han K, et al. Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma [J]. Eur Radiol, 2017, 27(6): 2610-2618.
[31] Yu GR, Kim SH, Park SH, et al. Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma [J]. Exp Mol Med, 2007, 39(5): 641-652.
[32] Kim SU, Jung KS, Lee S, et al. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma [J]. Liver Int, 2014, 34(7): 1008-1017.
[33] Plessier A, Codes L, Consigny Y, et al. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma [J]. Liver Transpl, 2004, 10(2): 86-90.
[1] YU De-Xin, CAEI Ti-Gong, MA Xiang-Xing, ZHANG Xiao-Ming, LI Chuan-Fu. Angiogenesis and maturation of hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 51-54.
[2] LV Yan-Feng, DING Ke, WANG Jian-Xin, YU Hua-Long, BEI Shao-Sheng. Canceration of chronic anal fistula [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 55-57.
[3] LI Bo-Bo, LI Dao-Tang, LIU Shu-Guang, WANG Xing-Wu. Expression of serum DKK-1 in esophageal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 58-61.
[4] XU Ping, YU Guo-Fang, LI Xia. Differential diagnosis of Graves′ disease and Hashimoto′s thyroiditis by different types peak systolic velocity of the superior thyroid artery [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 62-64.
[5] WANG Xin, XING Chun-Yan, YANG Yan-Ping. Serum phosphopyruvate hydratase in diagnosis of invasive Candida albicans infection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 92-94.
[6] FENG Baomin, WANG Zhou, XU Han, LI Jiacun, YU Qiaowen, XIU Jianjun. Clinical and imaging features of 19 cases of anti-myelin oligodendrocyte glycoprotein-IgG antibody associated disorders [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 45-50.
[7] SONG Yufeng, NING Hao, YAO Zhigang, WU Haihu, LIU Feifan, LYU Jiaju. Clinical and imaging features of adrenal cavernous hemangioma [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 37-42.
[8] PAN Pengfei, XU Lisheng, JI Kunqian, WANG Dexiang, LI Yu. Mitochondrial myopathy beginning with respiratory failure: one case and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 54-59.
[9] CHEN Gang, ZHANG Yanping, YE Leping, FU Chong, ZHOU Chunyan, ZHANG Shidong. Diagnostic value of contrast-enhanced endoscopic ultrasonography combined with endoscopic ultrasound-guided fine needle aspiration for pancreatic masses [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 68-73.
[10] Xiaoping XING. Diagnosis and management of primary osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 1-4.
[11] LIU Xueye, LI Qiming, TANG Hongyi, XU Qiuping, CHEN Wenqian, GUO Jing. Relationship among the volume and surface area of the temporomandibular joint condyle and the sagittal position of disc in young adults [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 117-121.
[12] ZHANG Gaorui, ZHANG Yuting, ZHAO Yuxuan, WANG Fangqing, YU Dexin. Value of MnFe2O4@CNS in the theragnostic of pancreatic cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 48-55.
[13] SUN Dingqi, FU Qiang, ZHANG Hui, LIU Shuai, DIAO Tongxiang, CAO Qingwei, ZHANG Keqin. Clinical value of targeted multiparameter MRI and transrectal ultrasonography fusion prostate biopsy for the detection of PI-RADS≥3 prostate cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 108-113.
[14] SONG Zhenzhen, SUN Xiaoling, LI Haiou, WANG Fang, ZHANG Ran, YU Dexin. Value of MRI radiomics of glioma and peritumoral edema in evaluating tumor recurrence [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 53-60.
[15] Guoyun WANG,Kai WANG,Ming YUAN,Zijiang CHEN. Multidimensional management system for endometriosis (The Program for Shandong Province) [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 1-16.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!